According to our hypothesis, the BLM inhibitor ML216 makes PCa cells more susceptible to CDDP by obstructing DNA repair and cell cycle checkpoint functions, which leads to abnormal mitotic entry and cell death. This evidence concerns the gene BLM and posterior cortical atrophy.